Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Apr;18(3):917-928.
doi: 10.1007/s11739-022-03161-z. Epub 2023 Jan 7.

Clinical testing of the cardiovascular effects of e-cigarette substitution for smoking: a living systematic review

Giusy La Rosa  1 , Robin Vernooij  1   2   3 , Maria Qureshi  1   4 , Riccardo Polosa  1   5 , Renée O'Leary  6
Affiliations

Clinical testing of the cardiovascular effects of e-cigarette substitution for smoking: a living systematic review

Giusy La Rosa et al. Intern Emerg Med. 2023 Apr.

Abstract

Some persons who smoke have substituted e-cigarettes for tobacco cigarettes, either completely or partially. What effect does this have on cardiovascular functioning? We conducted a living systematic review on human clinical studies measuring the cardiovascular effects of e-cigarette substitution for smoking. The Scopus, PubMed, and CENTRAL Cochrane Library databases were searched on January 31 and April 29, 2021. Three secondary searches and a grey literature search were conducted. Included study designs were randomized controlled trials, quasi-experimental clinical trials, and cohort studies. Risk of bias and study quality were evaluated with the JBI Critical Appraisal tools and the Oxford Catalogue of Bias. The systematic review covered 25 studies comprising 1810 participants who smoked. Twenty studies were rated at high risk of bias, and five as some concerns. A tabular synthesis by direction of effect was conducted due to heterogeneity in the data. Nearly two-thirds of the test analyses indicated that e-cigarette use had no significance difference compared with tobacco cigarettes on heart rate, blood pressure, and in other cardiovascular tests. In two studies, participants with hypertension experienced a clinically relevant reduction in systolic blood pressure after 1 year of e-cigarette use. E-cigarette substitution incurs no additional cardiovascular risks, and some possible benefits may be obtained, but the evidence is of low to very low certainty. An update search on May 30, 2022 retrieved five studies that did not alter our conclusion.Registration PROSPERO #CRD42021239094.

Keywords: Blood pressure; E-cigarette; ENDS; Harm reduction; Heart rate; Living systematic review; Risk of bias.

PubMed Disclaimer

Conflict of interest statement

RP is full tenured professor of Internal Medicine at the University of Catania (Italy) and Medical Director of the Institute for Internal Medicine and Clinical Immunology at the same University. He has received grants from U-BIOPRED and AIR-PROM, Integral Rheumatology & Immunology Specialists Network (IRIS), Founda- tion for a Smoke Free World, Pfizer, GlaxoSmithKline, CV Therapeu- tics, NeuroSearch A/S, Sandoz, Merk Sharp & Dohme, Boehringer Ingelheim, Novartis, Arbi Group Srl., Duska Therapeutics, Forest Laboratories and Ministero dell Universita’ e della Ricerca (MUR) Bando PNRR 3277/2021, CUP E63C22000900006, funded by NextGenerationEU, the European Union (EU) economic recovery package. He is founder of the Center for Tobacco Prevention and Treatment (CPCT) at the University of Catania and of the Center of Excellence for the Acceleration of Harm Reduction at the same university. He receives consultancy fees from Pfizer, Boehringer Ingelheim, Duska Therapeutics, Forest Laboratories, CV Therapeutics, and Sermo Inc. He is being paid textbook royalties from Elsevier. He is also involved in a patent application for ECLAT Srl. He is a pro bono scientific advisor for Lega Italiana Anti Fumo (LIAF) and the International Network of Nicotine Consumers Organizations (INNCO); and he is Chair of the European Technical Committee for Standardization on “Requirements and test methods for emissions of electronic cigarettes” (CEN/TC 437; WG4).

Figures

Fig. 1
Fig. 1
PRISMA flow diagram
Fig. 2
Fig. 2
Testing outcomes, acute heart rate
Fig. 3
Fig. 3
Testing outcomes, follow-up heart rate
Fig. 4
Fig. 4
Testing outcomes, blood pressure
See this image and copyright information in PMC

References

    1. World Health Organization (2020) Tobacco. https://www.who.int/news-room/fact-sheets/detail/tobacco. Accessed 16 Dec 2020
    1. Institute for Health Metrics and Evaluation (2020) GBD compare Viz Hub (2020). https://vizhub.healthdata.org/gbd-compare/
    1. Benowitz NL, Fraiman JB. Cardiovascular effects of electronic cigarettes. Nat Rev Cardiol. 2017;14:447–456. doi: 10.1038/ncardio.2017.36. - DOI - PMC - PubMed
    1. MacDonald A, Middlekauff HR. Electronic cigarettes and cardiovascular health: what do we know so far? Vasc Health Risk Manag. 2019;15:159–174. doi: 10.2147/VHRM.S175970. - DOI - PMC - PubMed
    1. Tarran R, Barr RG, Benowitz NL, Bhatnagar A, Chu HW, Dalton P, et al. E-cigarettes and cardiopulmonary health. Functon. 2021;2(2):zqab004. doi: 10.1093/function/zqab004. - DOI - PMC - PubMed

Publication types